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Abstract 
Objective: Gut derived ILC3 have been demonstrated to participate in AS pathogenesis. 
CX3CR1+ mononuclear phagocytes (MNP) have been demonstrated to modulate ILC3 
function in the gut. The aim of this study was to study the role of pro-inflammatory 
CX3CR1+CD59+ MNP in modulating ILC3 function in AS patients.  
Methods: MNP subsets in blood were analysed by flow cytometry in AS patients and 
controls. Tissue presence of CX3CR1+CD59+ cells was confirmed by confocal microscopy. 
Expression of pro-inflammatory chemokine CX3CL1, CCL2 and decoy receptor D6 was 
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studied. Peripheral CX3CR1+CD59+ cells were co-cultured with ILC3 and changes in their 
frequency evaluated by flow cytometry. Transcriptomic analysis of circulating CX3CR1 
monocytes was also performed. 
Results: D6 deficiency and CCL2 over-expression was observed in AS inflamed tissues. In 
the gut pro-inflammatory CX3CR1+CD59+ MNP population was expanded, correlated with 
the presence of bacteria and produced high levels of TL1A and IL-23. CD11b+CD11c+MHC 
class II+ MNP, predominantly expressing CX3CR1, were also expanded in naïve SKG 
relative to BALB/c mouse small intestine. Gut-derived CX3CR1+CD59+CCR9+TL1A+IL-23+ 
MNP frequency was significantly higher in AS peripheral blood and synovial fluids. 
CCR9+CX3CR1+CD59+ monocytes were also expanded in AS synovial and bone marrow 
samples. Transcriptomic analysis of isolated CX3CR1+CD59+ monocytes demonstrated a 
specific pro-inflammatory profile in AS. Isolated pro-inflammatory CX3CR1+CD59+ MNP from 
AS induced the expansion and activation of ILC3.  
Conclusions: Pro-inflammatory CX3CR1+CD59+TL1A+IL-23+ MNP are expanded in AS 
patients displaying a specific pro-inflammatory transcriptomic profile. Given the ability of 
these cells in supporting ILC3 expansion, they may promote a sustained pro-inflammatory 
status in AS. 
 
Keywords: CX3CR1+ monocytes, IL-23, TL1A, gut inflammation, ILC3 
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Subclinical gut inflammation has been demonstrated to occur in a significant percentage of 
patients with Ankylosing Spondylitis (AS) and is possibly one of the most important sites 
where interleukin (IL)-23 production takes place.[1] Intestinal IL-23 appears to be 
responsible for the induction of innate immune responses such as expansion and activation 
of type 3 innate lymphoid cells (ILC3) in AS.[2] Despite their mucosal origin, gut-derived 
α4β7+ILC3, are expanded in the peripheral blood, synovial fluid and bone marrow (BM) of 
patients with AS, suggesting their active recirculation between the gut and the site of active 
inflammation.[2] However, the factors influencing the maintenance of ILC3 in an activated 
state in extra-intestinal sites are not clear. 
Recently CX3CR1+ mononuclear phagocytes (MNP), strategically located near murine and 
human gut epithelium, have been demonstrated to produce high levels of IL-23 and TL1A 
efficiently supporting IL-22 production from ILC3.[3] Although CX3CR1+ MNP have been 
considered as resident macrophages, recent evidence suggests that during intestinal 
inflammation, they may acquire migratory potential and move to secondary lymphoid organs, 
initiating immune responses.[4] 
In mice, the intestinal replenishment of the CX3CR1+ phagocytes come from newly arrived 
and recently divided Ly6ChiCCR2+ monocytes.[5] The trafficking of murine Ly6C+ monocytes 
is regulated by the tissue expression of atypical chemokine receptor D6.[6] D6 is a decoy 
and scavenger receptor for most inflammatory CC chemokines, including CCL2, and helps 
prevent tissue inflammatory reactions.[7] Mice lacking D6 expression in the non-
hematopoietic compartment display a significant increase of pro-inflammatory monocytes in 
the peripheral blood and in secondary lymphoid tissues in a CCR2-dependent manner.[6] 
Thus the net CX3CR1 mediated immune response likely is affected by the balancing effects 
of CCL2 and D6. 
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The immunological behaviour of CX3CR1+ MNP in AS patients has not yet been 
investigated. Here we report the tissue frequency and distribution of intestinal pro-
inflammatory CX3CR1+ MNPs, and their distribution in the peripheral blood and inflamed 
tissues of AS patients. Finally, we performed a transcriptomic analysis of circulating CXCR1+ 
monocytes from AS and evaluated their role in ILC3 activation. 
 
Methods  
 
Ethical statement 
The study was conducted according to the Declaration of Helsinki and Italian legislation. 
Consent was obtained from all enrolled subjects after the nature of the investigation was 
explained and in accordance with the approved protocol from the institute review board at 
the University of Palermo (5/2014 16042014) and the University Health Network, Toronto. 
Patients 
Twenty-five consecutive HLA-B27 AS patients, fulfilling the modified New York criteria [8] 
with active disease defined as an AS disease activity score (ASDAS) [9] of 2 or more were 
enrolled in this study. We also enrolled patients affected by Crohn’s disease (CD) (n=5) with 
active disease as control disease. All patients underwent ileocolonscopy independent of the 
presence of gastrointestinal symptoms. Twenty healthy individuals, matched by sex and 
age, without evidence of intestinal disease, undergoing ileocolonoscopy for diagnostic 
purposes were enrolled as healthy controls. Multiple (five) adjacent ileal mucosal biopsies 
were obtained from each patient and control to a total of 125 biopsies in AS, 25 in CD and 
100 in controls. Gut specimens obtained from patients with AS were histologically divided 
into three groups as previously described,[2] normal gut histology, acute and chronic 
inflammation. Synovial samples and synovial fluids were also obtained from additional 5 
patients with peripheral spondyloarthritis with active disease at the time of sample collection, 
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from 5 patients with osteoarthritis and from 5 patients with Rheumatoid arthritis (RA). Bone 
marrow samples were obtained from 5 AS patients with active disease and 
hypergammaglobulinemia and 5 controls without any history of inflammatory joint disease, 
undergoing BM biopsy for diagnostic purpose. In both patients and controls the number of 
plasma cells was <10% also displaying a normal phenotype (CD38+CD56−CD19+). Baseline 
characteristics of patients and controls are specified in Table 1. 
 
RNA extraction and quantitative TaqMan real-time PCR (RT-PCR) for ileal biopsies 
Total RNA was extracted by using the Qiagen RNeasy Mini kit, with on-column DNase I 
digestion as previously described.[2] Quantitative TaqMan real-time PCR, sets of primers 
and probes were obtained from Applied Biosystems (Foster City, CA) (see supplemental 
table 1). Both 18S and GADPH were used as housekeeping genes, giving comparable 
results. GADPH was used for the final results shown. Samples were run in triplicate using 
the Step-One Real-Time PCR system (Applied Biosystems) and relative changes in gene 
expression between controls and patients were determined using the ΔΔCt method as 
previously described.[2] Final values were expressed as fold of induction. 
Immunohistochemistry and confocal microscopy analysis 
Immunohistochemistry for D6, CCL2 and CX3CL1 and confocal microscopy analysis was 
performed on paraffin-embedded sections of gut, synovial and BM samples as previously 
described.[2] Tonsils samples were considered as positive controls. A list of primary and 
secondary antibodies used is provided in supplementary table 2. Quantification of labelled 
cells was assessed by two independent investigators (FC and AR) by manually counting the 
positive cells on photomicrographs obtained from three random high-power microscopic 
fields (original magnification, 400×) under a Leica DM2000 optical microscope using a Leica 
DFC320 digital camera. The intra-rater agreement and the inter-rater agreement calculated 
by the Cohen’s K coefficient for the two observers were 0.8 and 0.76, respectively. For more 
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details see supplemental methods. In order to detect bacteria, the highly sensitive Warthin-
Starry silver/nitrate-based staining method, Gram staining and an antibody directed against 
bacterial lipopolysaccharide (LPS) were used as previously described [10]. For more details 
see supplemental methods.  
ELISA for CX3CL1 and CCL2 
Serum was collected in all patients and controls for ELISA. All samples were centrifuged at 
1200 rpm for 10 minutes at 4°C immediately after collection, flash freezing in liquid nitrogen 
in order to avoid protein degradation and then stocked at -80°C until the analysis. The range 
of storage for patients was 12±6 months for the patients and 9±5 months for the controls. 
Human CX3CL1 and CCL2 were analysed in sera employing sandwich-ELISA kits (Abcam, 
Cambridge for CX3CL1 and R&D for CCL2) following the manufacturer’s instructions 
(measurable concentration range of 0.25 to 60 ng/mL for CX3CL1 and 31.2 - 2000 pg/mL for 
CCL2). All results were analysed using a five parameter-logistic (5PL) function for fitting 
standard curves obtained from recombinant protein standards. 
Isolation of lamina propria, peripheral blood and synovial fluid mononuclear cells  
Lamina propria mononuclear cells (LPMCs), peripheral blood mononuclear cell (PBMCs) 
and synovial fluid mononuclear cells (SFMCs) were respectively isolated from the gut, the 
peripheral blood and synovial fluid of patients with AS, RA and healthy controls as previously 
described.[2] For the phagocytosis assay, CX3CR1+CD59+ monocytes were FACS sorted by 
using CD14, CX3CR1 and CD59 specific antibodies. Fore more details see supplemental 
methods. A list of the antibodies used is provided on the online supplemental table S1.  
Flow cytometry analysis of surface and intracellular antigens 
Different monocyte subsets were analysed by flow cytometry in the peripheral blood, gut, 
synovial fluids of AS patients and controls. LPMC and PBMCs were isolated respectively 
from the gut biopsies and peripheral blood of all patients and controls as previously 
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described by GG with no access to histological and clinical data.[2] Paired SFMCs were also 
obtained from 5 AS patients, who underwent to ileocolonoscopy, and 5 OA patients. A list of 
the antibodies used is provided in supplemental table 1. Flow cytometric analysis was 
performed using a FACSCanto and FACScalibur (Becton Dickinson, Franklin Lakes, New 
Jersey), and cell death was assessed by trypan blue exclusion. At least 50 000 cells (events) 
were acquired for each sample. Lamina propria mononuclear cells (LPMCs) were expressed 
as percentage of cells within the lymphocyte gate. The acquired data were analysed using 
CellQuest and FlowJo software programs. 
Cell cultures 
In order to evaluate the role of CX3CR1+ in regulating the differentiation of ILCs type 3, 
CX3CR1+ MNP were isolated from the peripheral blood of AS patients by using CX3CR1 
microbeads (positive selection) and magnetic-activated cell sorting (MACS) techniques 
(Miltenyi Biotech GmbH, Bergisch Gladbach, Germany) according to the manufacturer’s 
instructions. CD45+lin− mononuclear cells were enriched in ILC3 precursors. CD45+lin− 
mononuclear cells were isolated from tonsils of normal donors as previously described using 
lineage-marker (negative depletion with antibodies to CD5, CD45R (B220), CD11b, Gr-1 
(Ly-6G/C), 7-4 and Ter-119) and c-kit microbeads (positive selection) and MACS (Miltenyi 
Biotech GmbH, Bergisch Gladbach, Germany) according to the manufacturer’s instructions. 
Isolated CX3CR1+ MNP and CX3CR1- MNP were then cultured with isolated CD45+ lin− 
precursor-enriched mononuclear cells (1:1), and the percentage of ILC3 was assessed by 
flow cytometry. All cultures were set up in triplicate and cells were used for flow cytometric 
analyses. 
Transcriptomic analysis 
PBMCs from 7 AS patients and 5 HC were isolated by density gradient centrifugation after 
layering blood on Ficoll-Paque (GE Healthcare) and CX3CR1+CD59+ monocytes were FACS 
sorted by using CD14, CX3CR1 and CD59 specific antibodies. Total RNA was isolated by 
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using TRIzol (Thermo Fisher Scientific) and further purified by using RNeasy MinElute 
cleanup kit (Qiagen). RNA samples were assessed on a RNA 6000 Pico chip (Agilent 
Technologies) by using the Agilent Bioanalyzer to determine sample RIN and quantified by 
the Qubit RNA HS assay kit (Life Technologies). All samples used had RIN values greater 
than 8. For more details see supplemental methods.  
 
Isolation and staining of murine intestinal lamina propria cells 
SKG and BALB/c mice housed under SPF conditions and/or injected with with 1,3-β- glucan 
(curdlan) at The University of Queensland Translational Research Institute (TRI) Animal 
Facility. Approval for all experiments was obtained from The University of Queensland 
animal ethics committee. Lamina propria Lymphocytes (LPL) were isolated from naïve 
BALB/c and SKG small intestine (SI) after dissecting Peyer's patches and fat removal. For 
more details see supplemental methods. 
Statistical analysis 
Student's t-test or the nonparametric Mann-Whitney test was used to calculate the statistical 
significance between groups. Paired samples were analysed with the Wilcoxon signed-rank 
test. Spearman’s rank correlation was used to calculate the correlation between different 
variables in AS.  p values less than 0.05 were considered significant.  
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Results 
CX3CR1+CD59+ monocytes producing IL-23 and TL1A are expanded in the gut of AS 
patients and correlated to presence of ileal bacteria 
We first studied the frequency and distribution of different MNP subsets in the gut of AS  and 
CD patients and HC. Accordingly to our previous demonstration, [11] in the inflamed ileum of 
AS patients, despite a global expansion of MNP (figure 1A-B), we observed a significant 
down-regulation of CD14 expression (Figure 1A-B) compared to healthy controls 
(supplemental Figure 1A). Due to the low levels of CD14 monocyte expression in AS gut, we 
could not separately analyse classical, intermediate and non-classical monocytes. Since Ly6 
is a murine marker, for the further characterization of monocytes we used CD59, the human 
homologue.[12] Pro-inflammatory CX3CR1+CD59+, but not resident CX3CR1+CD59- (data 
not shown) monocytes were expanded in the gut of AS patients (Figure 1C-D) compared to 
CD patients (Figure 1D and supplemental figure 1B) being undetectable in controls (data not 
shown). The majority of inflammatory CX3CR1+CD59+ monocytes produced both TL1A and 
IL-23 and expressed CCR9 (figure 1C,D). IL-23, TL1A and its receptor Death receptor 3 
(DR3), expression was confirmed in AS ileal samples by RT-PCR (Figure 1E-G). 
Interestingly, the CX3CR1+CD59+ monocyte frequency was significantly correlated with the 
percentage of intestinal ILC3 (Figure 1H) and with the bacterial scores (Figure 1I). The 
tissue distribution of CX3CR1+CD59+ monocytes, studied by confocal microscopy analysis 
demonstrated their location close to crypt intestinal epithelial cells (Figure 1J-M) and to 
tissue CD3-Thy1+Tbet+ ILC3 (Figure 1N-O).  
CD11b+CD11c+MHC class II+ MNP, predominantly expressing CX3CR1 are expanded in 
naïve SKG small intestine  
BALB/cW163C ZAP70-mutant (SKG) mice develop IL-23-dependent SpA-like disease after 
intraperitoneal administration of beta-1,3-glucan (curdlan), with peripheral and axial arthritis, 
enthesitis, psoriasiform inflammation of the skin and Crohn’s-like ileitis [13-14]. Although 
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naïve SKG mice are healthy, they have fecal microbial dysbiosis relative to control BALB/c 
mice, and IL-23 is constitutively expressed in the ileum [13]. In naïve SKG mice, 
predisposed to SpA development, we compared the frequency of the small intestinal MNP 
relative to BALB/c controls. MNP were CD11b+CD11c+MHC class II+, and expressed either 
CX3CR1 (intestinal macrophages) or CD103 (dendritic cells) (Figure 2A, B) [3]. MNP were 
significantly expanded in SKG relative to BALB/c small intestine. Expanded cells were 
predominantly CX3CR1+, while CD103+ MNP were significantly less frequent (Figure 2C). 
Interestingly, SKG mice challenged with Curdlan showed a significant further expansion of 
CX3CR1+ MNP (Figure 2 C). 
D6, CCR2 and CCL2 expression in the gut, bone marrow and synovia of AS patients 
In mice, CX3CR1+ monocytes appear to be derived from circulating Ly6C+CCR2+ monocytes 
in a D6-dependent manner.[5] Considering the role of D6 in controlling the trafficking of 
murine Ly6C+ monocytes, we subsequently evaluated the expression of D6 in different 
inflamed tissues of AS patients. A global reduction of D6 expression was observed in the gut 
(independently of the degree of intestinal inflammation) (Figure 3A-D), bone marrow (Figure 
3E-G) and synovial samples (Figure 3H-J) of AS patients compared to controls. Along with 
the reduced levels of D6, significantly increased expression of CCL2 and CCR2 was 
observed in AS gut (Figure 3K-L and Supplemental Figure 2A-C), synovia (Figure 3M-N and 
Supplemental Figure 2D-F) and BM (Figure 3O-P and supplemental Figure 2G-I) samples. 
Interestingly, the reduced D6 expression in AS inflamed tissues was paralleled by increased 
levels of CCL2 in AS serum compared to controls (data not shown). 
CD14++CD16+CCR9+CX3CR1+CD59+ monocytes are expanded in the peripheral blood, 
synovial fluid, synovial and bone marrow samples of AS patients 
CCR9 has been shown before to be a gut homing marker [15,16]. We studied whether tissue 
D6 deficiency could be accompanied by an increased frequency and tissue distribution of 
gut derived CD14++CD16+CCR9+CX3CR1+CD59+ cells in the peripheral blood and inflamed 
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tissues of AS patients. As shown in figure 2, an increased frequency of 
CD14++CD16+CX3CR1+CD59+CCR9+IL-23+TL1A+ cells was observed in the peripheral blood 
(Figure 4B-C) of AS patients, being undetectable in controls (data not shown). Since their 
expression of CCR9, a marker of intestinal homing, we assumed that that these cells were of 
gut origin. The frequencies of circulating CD14++CD16+CX3CR1+CD59+CCR9+IL-23+TL1A+ 
were significantly and directly correlated with the frequencies of circulating ILC3 (Figure 4D), 
with the disease activity as assessed by BASDAI (Figure 4E) and C-reactive protein (CRP) 
(Figure 4F). Interestingly, isolated CD14++CD16+CX3CR1+CD59+CCR9+IL-23+TL1A+ from the 
peripheral blood, displayed in AS a more pronounced phagocytic activity compared to 
controls (Figure 4G). A significant expansion of CD14++CD16+CCR9+CX3CR1+CD59+IL-
23+TL1A+ was also demonstrated in AS synovial fluids (Figure 4H, I) and RA (Supplemental 
Figure 1C), being undetectable in controls (data not shown). Confocal microscopy analysis 
confirmed the presence of either scattered or aggregated CX3CR1+CD59+ cells also in the 
context of inflamed AS synovial  (Supplemental Figure 3 A-E) and bone marrow tissues 
(Supplemental Figure 3G-M). Similar to the gut, a close spatial relationship between 
CX3CR1+ cells and CD3-Tbet+ cells was observed in the inflamed AS tissues (Supplemental 
Figure 3F and N), suggesting a role of these cells in modulating ILC3 responses. 
CX3CL1 levels are increased in the inflamed tissues but not in the peripheral blood of 
AS patients 
As we found an expansion of CX3CR1+ monocytes in the peripheral blood and in the 
inflamed tissues of AS patients, we measured the expression of its cognate ligand CX3CL1 
by ELISA, RT-PCR and immunohistochemistry. Compared to controls, significant CX3CL1 
over-expression was observed in AS gut (Figure 5A-D), synovial  (Figure 5E-G) and bone 
marrow samples (Figure 5H-J). In AS gut and bone marrow samples, CX3CL1 expression 
was essentially observed in endothelial cells and inflammatory mononuclear cells. CX3CL1 
vascular expression predominates in AS synovial samples. Contrary to tissue expression, 
serum levels of CX3CL1 were similar in AS patients and controls (data not shown). 
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Isolated CX3CR1+CD59+ cells drive ILC3 expansion 
Since CX3CR1+ cells have been demonstrated to expand ILC3 in the gut, we next evaluated 
the role of isolated CX3CR1+CD59+ MNPs in modulating ILC3 expansion and activation. 
Isolated intestinal and circulating CX3CR1+CD59+ MNPs were co-cultured with isolated 
peripheral ILC3. Despite ILC3 have been described to express the transcription factor 
RORc, we have previously demonstrated that in patients with AS these cells are almost 
totally Tbet+[2]. As shown in figure 6, in the presence of intestinal (Figure 6A-C) or circulating 
(Figure 6D-F) CX3CR1+ MNPs we observed a significant activation of Lyn−Tbet+NKp44+ 
ILC3 producing IL-22, indicating a direct role of these cells in modulating ILC3 expansion. 
Transcriptomic analysis of peripheral CD14+CX3CR1+CD59+ cells in AS patients 
We finally investigated the transcriptome of CD14+CX3CR1+CD59+ monocytes, isolated from 
PBMC, to understand the differences in the biological processes and cellular pathways 
between AS and HC. To generate the specific gene expression profile, we focused on genes 
satisfying the following criteria: (a) showed ≥ 1 Fragments Per Kilobase of transcript per 
Million mapped reads (FPKM) of 1 or greater in at least one of the sample across all 
samples and (b) were differentially expressed, with a fold change of 1.3 or greater between 
AS and HC. We identified a total of 159 genes that were differentially expressed out of the 
23620 genes identified from RNA-Seq. A total of 104 genes including TNF, CXCL2, JAK3, 
MAP3K8, ERAP2, MAP1LC3B, ATF4, NAIP, ZFP36L1 were significantly up-regulated in AS 
whereas 55 genes including TNFSF14, IL7R, granzyme A, granzyme B, granulysin, IL-2R 
and IL-5R were significantly down-regulated in AS (Supplemental Figure 4A). Granzymes 
are part of the recently described cytotoxic gene signature in the ‘Mono4’ population of 
monocytes (cytotoxic monocytes).[17] Pathway analysis including biological processes and 
immune system processes functions was performed with all differentially expressed genes. 
The up-regulated genes were enriched for pathways related to chronic inflammation 
response, positive regulation of chemokine production and positive regulation of 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
inflammatory response (Supplemental Figure 4B). Conversely, the down-regulated genes 
were enriched for pathways related to leukocyte chemotaxis, leukocyte and mast cells 
mediated immune responses (Supplemental Figure 4C).  
 
Discussion 
This study supports the concept that a subset of pro-inflammatory CX3CR1+CD59+ 
monocytes, producing IL-23 and TL1A are expanded in the inflamed gut of AS patients and 
of SKG mice and in the sites of active inflammation in AS, sustaining the activation of ILC3. 
In addition, we provide transcriptomic analysis of isolated CX3CR1+CD59+ MNP that showed 
a specific pro-inflammatory signature in AS compared to healthy controls.  
Gut-derived ILC3, producing IL-17 and IL-22, are expanded in the peripheral blood and 
inflamed tissues of AS patients. [2] However, the factors involved in their expansion and 
maintenance in an activated status are not completely clear. Recently, CX3CR1+ intestinal 
MNP have been demonstrated to efficiently support IL-22 production from ILC3 both in mice 
and humans.[3] Murine MNP can be classified into two distinct populations, inflammatory 
MNP (CX3CR1+Ly6+) and resident MNP (CX3CR1+Ly6-cells).[18] In humans classical 
(CD14++CD16−) monocytes resembling Ly6+ monocytes, intermediate (CD14++CD16+) 
monocytes playing pro-inflammatory roles and non-classical (CD14+CD16++) patrolling 
monocytes have been demonstrated.[18] In the gut of AS patients, despite a global 
expansion of MNP we observed a decreased frequency of CD14+ cells. As CD14 is down-
regulated in intestinal MNP [19] to avoid dangerous immune responses, we speculate that 
the decreased levels of CD14 in AS patients could be related to differences in bacterial 
ileum colonization from controls [10]. Despite the CD14 down-regulation, the frequency of 
CX3CR1+CD59+ MNP was significantly increased in the gut of AS patients and correlated 
with the bacterial scores. These CX3CR1+CD59+ cells were characterized by the intense 
production of IL-23 and TL1A and aided the expansion of ILC3. Hence, we believe that 
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these cells are the human counterparts of murine CX3CR1+Ly6c+ pro-inflammatory MNP. 
The CX3CR1+CD59+ MNP were located close to intestinal crypt epithelial cells and to lamina 
propria ILC3. In mice, CX3CR1+ MNP are essential in maintaining LP MNP populations and 
preventing translocation of commensal bacteria to mesenteric lymph nodes. In naïve SKG 
mouse intestine characterised by intestinal dysbiosis and IL-23 over-expression, MNP 
expressing CX3CR1 were also increased, suggesting recruitment of dysbiosis-associated 
inflammatory monocytes to the intestine, prior to the development of disease. After Curdlan 
challenging, the frequency of MNP expressing CX3CR1 was further increased suggesting a 
role in triggering Crohn’s-like ileitis and SpA in the SKG model. These observations, together 
with the evidence that in AS the frequency of CX3CR1+CD59+ MNP significantly correlated 
with the percentages of intestinal ILC3, might indicate the importance of these cells in 
bridging immune responses from the intestinal lumen to the innate immune system.  
In mice, the intestinal replenishment of the CX3CR1+ MNP derives from newly arrived 
Ly6ChiCCR2+ monocytes in a D6-dependent manner.[5] D6 is a decoy and scavenger 
receptor for most inflammatory CC chemokines and recent evidences indicated that after D6 
engagement, CCL2 is rapidly internalized and degraded suggesting that this receptor acts a 
chemokine- scavenging decoy receptor.[20-21] Thus a deficiency of D6 can lead to excess 
pro-inflammatory chemokine (eg. CCL2) accumulation. D6 deficient mice have a delay in the 
clearance of inflammatory CC chemokines and under inflammatory conditions display a 
significant increase in Ly6Chigh MNP in secondary lymphoid organs.[6] Along with the 
increased frequency of tissue and circulating CX3CR1+CD59+ MNP in AS, we observed a 
significant decreased expression of D6 in the inflamed gut, synovial and bone marrow 
tissues. D6 deficiency was paralleled by an increase in tissue and systemic expression of 
CCL2 as well as an increase in CX3CR1+CD59+ cells. These findings seem to support a role 
for D6 deficiency in increased MNP mobilization to the inflamed AS tissues via the control of 
CCR2 ligand concentrations in the tissues and in the bloodstream. 
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CX3CR1+ MNP have been long considered as resident macrophages. However, recent 
evidence suggests that they may acquire migratory potential to secondary lymphoid organs 
and initiate immune responses.[4] Although the majority of intestinal CX3CR1+CD59+ cells 
lie in the CD14(low) population, we decided to not analyse these cells in the AS peripheral 
blood and synovial fluids. Human CD14(low) monocytes are in fact considered patrolling 
monocytes with weak phagocytic ability and not producing pro-inflammatory cytokines.[22] 
We were interested to study the intermediate population of monocytes that are activated in 
the gut that are able to produce pro-inflammatory cytokines. In AS patients, 
CD14++CD16+CX3CR1+CD59+IL-23+TL1A+ pro-inflammatory MNP were expanded in the 
peripheral blood and synovial fluids. A significant percentage of these cells expressed the 
marker of intestinal homing CCR9,[15] possibly indicating their intestinal origin. Importantly, 
the frequencies of circulating CD14++CD16+CX3CR1+CD59+CCR9+IL-23+TL1A+ monocytes 
were significantly correlated with the frequencies of circulating ILC3 as well as with disease 
activity. The presence of CX3CR1+CD59+ cells was also confirmed in synovial tissues and 
bone marrow obtained from AS patients where they were in close proximity to tissue ILC3. 
This spatial association may indicate an important role of these cells in supporting ILC3 
activation and expansion in extra-intestinal sites as well. This hypothesis is supported by our 
demonstration that isolated CD14++CD16+CX3CR1+CD59+ MNP from the gut and peripheral 
blood of AS patients activated IL-17 and IL-22 producing ILC3. CX3CL1 is the chemokine 
controlling the tissue migration of CX3CR1+ cells.[23] Despite the expansion of CX3CR1+ 
cells in AS peripheral blood we did not observe any significant increase in circulating 
CX3CL1. However, CX3CL1 expression was high in the AS inflamed gut, synovial and bone 
marrow tissues indicating its role in tissue migration of CX3CR1-expressing inflammatory 
MNP. 
It is noteworthy, that transcriptomic analysis performed on AS patients and controls 
demonstrated a specific pro-inflammatory phenotype of AS CX3CR1+CD59+ monocytes. 
Among the 159 genes that were differentially expressed in AS patients from controls, 104 
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genes were up regulated in AS. Among these genes, pro-inflammatory cytokines and 
chemokines such as TNF, CXCL2 and LT4 and intracellular mediator of cytokine signalling 
such as JAK3 and MAP3K8 were significantly over-expressed in AS. We also found a 
significant over-expression of genes involved in innate immune pathways such as 
inflammasomes (NAIP) and autophagy (MAP1LC3B and ATF4), in the misfolding of HLA-
B27 (UBE2J1), and in osteoblast and osteoclast activation. The role of CX3CR1+ monocytes 
on bone homeostasis is not known. It was beyond the scope of the current study to explore 
the link between CX3CR1+ monocytes and spinal ankylosis. Pathway analysis, finally, 
demonstrated the enrichment of genes related to chronic inflammation, positive regulation of 
chemokine production and positive regulation of inflammatory responses.  
In conclusion, this study provides the first evidence that migrating MNP acquire in the gut of 
AS patients a pro-inflammatory CX3CR1+ phenotype and re-circulate via the peripheral 
blood to inflamed AS tissues in a CX3CL1-dependent manner. CX3CR1+ monocytes, 
displaying a specific pro-inflammatory transcriptomic phenotype in AS patients, actively 
participate in the activation and expansion of ILC3. 
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Figure legends 
Figure 1. CX3CR1+CD59+ monocytes are expanded in AS gut. A-B: percentages of 
monocytes and of CD14+ monocytes in the gut of AS patients and controls. C: gating 
strategy and representative dot plot showing CX3CR1+CD59+IL-23+TL1A+CCR9+ 
monocytes in the gut of a patient with AS. D: percentages of CX3CR1+CD59+IL-
23+TL1A+CCR9+ monocytes in AS patients and controls. E-G: relative m-RNA levels of IL-
23p19 (E), TL1A (F), DR3 (G) were assessed by RT-PCR in the ileal samples obtained from 
all the AS patients and HC. The percentage of CX3CR1+CD59+IL-23+TL1A+CCR9+ was 
significantly and directly correlated with percentage of gut ILC3 (H) and bacterial scores (I). 
J-K: representative confocal microscopy images of CX3CR1 (J), CD59 (K) and CD68 (L) in 
AS gut. M: merge triple staining showing CD68/CX3CR1/CD59 co-localization in AS gut. N-
O: representative confocal microscopy analysis showing co-localization of CX3CR1+ cells 
with CD3- (Cyan) Tbet+ (Red) ILC3 in AS gut (N); O: CD3 positive staining in the same 
section. J-O: original magnification x400. 
Figure 2. CX3CR1+ and CD103+ MNPs in SPF BALB/c and SKG gut. (A) Flow cytometric 
plots depicting gating strategy of the LPL (B). Representative flow cytometric plots of 
CX3CR1+ and CD103+ MNP from BALB/c and SKG lamina propria. Proportions of cell 
populations are shown in numeric values adjacent to gated boxes. (C). Frequency of MNP 
(MHC-II+CD11b+CD11c+ cells gated on live CD45.2+ cells), CX3CR1+ and CD103+ MNP 
cells from the BALB/c and SKG mice in specific pathogen free conditions (SPF) and after 
injection with 1,3-β- glucan (curdlan)  analyzed as in A. Statistical analysis was done 
according to Mann-Whitney U test considering mean ± SEM for each bar. Each dot in B 
represents an individual mouse. * P<0.05, ** P<0.005. 
 Figure 3. Figure 3. D6 and CCL2 expression in AS patients. A: relative m-RNA levels of 
D6 was assessed by RT-PCR in the ileal samples obtained from all patients and controls.  
B-C: representative images showing D6 immunostaining in the gut of AS patients (B) and 
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controls (C). D: number of D6+ cells/infiltrating cells in the gut of AS patients and controls. E-
F: representative images showing D6 immunostaining in the bone marrow of AS patients (E) 
and controls (F). G: number of D6+/infiltrating cells in the BM of AS patients and controls. H-
I: representative images showing D6 immunostaining in the synovial samples of patients 
with SpA (H) and controls (I). J: number of D6+/infiltrating cells in the synovial samples of 
patients with SpA and controls. K, M, O: representative images of CCL2 in the gut (K), 
synovial (M) and bone marrow (O) samples of AS patients. L, N, P: number of 
CCL2+/infiltrating cells cells in the gut (L), synovium (N) and bone marrow (P) of patients 
and controls.  
Figure 4. CX3CR1+CD59+ monocytes are expanded in AS peripheral blood and 
synovial fluids. A: representative dot plots showing the gating strategy in the peripheral 
blood of AS patients. B: representative dot plot showing CX3CR1+CD59+IL-
23+TL1A+CCR9+ monocytes in the peripheral blood of a patient with AS. C: percentages of 
CX3CR1+CD59+IL-23+TL1A+CCR9+ monocytes in the peripheral blood of AS patients and 
controls. D: percentages of circulating CX3CR1+CD59+IL-23+TL1A+CCR9+ monocytes was 
correlated with the percentages of circulating ILC3. E-F: percentages of circulating 
CX3CR1+CD59+IL-23+TL1A+CCR9+ monocytes was correlated in AS with the disease 
activity levels evaluated by the BASDAI (E) and with C-reactive protein (F). G: Phagocytosis 
index among isolated CX3CR1+CD59+ MNP. H: representative dot plot showing 
CX3CR1+CD59+IL-23+TL1A+CCR9+ monocytes in the synovial fluid of a patient with AS. I: 
percentages of CX3CR1+CD59+IL-23+TL1A+CCR9+ monocytes in the synovial fluids of AS 
and RA patients and controls.  
 Figure 5: CX3CL1 expression in AS inflamed tissues. A: relative m-RNA levels of 
CX3CL1 were assessed by RT-PCR in the ileal samples obtained from all the AS patients 
and HC. B-C: representative images showing CX3CL1 immunostaining in the gut of AS 
patients (C) and controls (B). D: number of CX3CL1+/infiltrating cells in the gut of AS 
patients and controls. E-F: representative images showing CX3CL1 immunostaining in the 
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synovial samples of patients with SpA (F) and controls (E). G: number of 
CX3CL1+/infiltrating cells in the synovial samples of patients and controls. H-I: 
representative images showing CX3CL1 immunostaining in the bone marrow of patients with 
AS (I) and controls (H). J: number of CX3CL1+/infiltrating cellscells in the bone marrow of 
patients with SpA and controls 
Figure 6: CX3CR1+ MNP drives ILC3 expansion. A-C: isolated CX3CR1+ (A) and 
CX3CR1-(B) cells were isolated from the gut of AS patients and co-cultured with isolated 
peripheral Lyn−Tbet+NKp44+ ILC3. There was significant expansion of IL22+Tbet+ ILC3 
with co-culture with both CX3CR1+ (A-C) cells and CX3CR1- cells (B-C)  compared to no 
co-culture. D-F: isolated CX3CR1+ (D) and CX3CR1- (E) cells were isolated from the 
peripheral blood of AS patients and co-cultured with isolated peripheral Lyn−Tbet+NKp44+ 
ILC3. There was significant expansion of IL22+Tbet+ ILC3 with co-culture with CX3CR1+ 
(D-F) cells but not with CX3CR1- cells (E-F)  compared to no co-culture. C, F: Percentages 
of ILC3 cells after co-culture with intestinal (C) and peripheral (F) CX3CR1+ and CX3CR1- 
cells. 
Supplemental Figure 1. Supplemental Figure 1. Representative dot plots showing 
CX3CR1+ monocytes in the gut of HC (A) and CD patients (B) and synovial fluids (C) of RA 
patients. 
Supplemental Figure 2: CCR2 expression in the inflamed tissues of AS patients. A: 
relative m-RNA levels of CCR2 was assessed by RT-PCR in the ileal samples obtained from 
all patients and controls. B-C: representative images showing CCR2 immunostaining in the 
gut of healthy controls (B) and AS patients (C). D: number of CCR2+ mononuclear cells 
(MNC)/infiltrating cells in the gut of AS patients and controls. E-F: representative images 
showing CCR2 immunostaining in the synovial samples of healthy controls (E) and SpA 
patients (F). G: number of CCR2+MNC/infiltrating cells in the synovial tissues of AS patients 
and controls. H-I: representative images showing CCR2 immunostaining in the bone marrow 
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samples of healthy controls (H) and AS patients (I). J: number of CCR2+MNC/infiltrating 
cells in the bone marrow of samples of patients with AS and controls. B-C, E-F, H-I: original 
magnification x400 
Supplemental Figure 3. CX3CR1+CD59+ are expanded in SpA inflamed synovial 
tissues and AS bone marrow tissues and are located in close proximity to ILC3. A-C: 
representative confocal microscopy images of CX3CR1 (A), CD59 (B) and CD68 (C) in SpA 
synovial tissues. D: merge triple staining showing CX3CR1/CD59/CD68 co-localization in 
SpA synovia. E: number of CX3CR1+CD59+CD68+ cells in patients and controls. F: merge 
triple staining of CX3CR1+ cells with CD3- (Cyan) Tbet+ (Red) ILC3 in SpA synovial tissues. 
CD3+ positive cells are observable in another portion of the same sections. G-I: 
representative confocal microscopy images of CX3CR1 (G), CD59 (H) and CD68 (I) in AS 
bone marrow tissues. L: merge triple staining showing CX3CR1/CD59/CD68 co-localization 
in AS bone marrow. CD3+ positive cells are observable in another portion of the same 
sections. M: number of CX3CR1+CD59+CD68+ cells in patients and controls. N: merge 
triple staining of CX3CR1+ cells with CD3- (Cyan) Tbet+ (Red) ILC3 in AS bone marrow 
tissues. A-D, F-L, N original magnification x 600. 
Supplemental Figure 4: Transcriptomic analysis of circulating CX3CR1+ AS 
monocytes. A: RNA-sequencing was done on flow-sorted CX3CR1+ monocytes. Differential 
gene expression between AS patients and Healthy controls was studied. Up-regulated 
(green to red) and down-regulated transcripts (yellow to blue) are shown as relative 
expression levels. B: Gene Functional enrichment network analysis among the genes 
highlighted in a. Network visualization of selected top enriched biological processes up-
regulated (left) and down-regulated (right) in AS patients. Each significantly enriched 
network (P<0.05) is represented with a circle and representative genes of the network. The 
node size represents the number of genes assigned to a biological process. C: hierarchical 
cluster analysis of gene expression in AS patients and controls 
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